Lantern Pharma Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Lantern Pharma Inc. (LTRN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $2.46 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-05-15
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.46K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.72K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.76K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.67K; Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed $11.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2025-12-31 | $2.46K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $3.72K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $6.76K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.67K 10-Q · filed 2026-05-15 | $11.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $16.40K 10-K · filed 2025-03-27 | |
| 2024-09-30 | $22.94K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $14.24K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $8.44K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $12.51K 10-K · filed 2024-03-18 | |
| 2023-09-30 | $17.32K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $22.86K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $21.55K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $513.00 10-K · filed 2023-03-20 | |
| 2022-09-30 | $1.43K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $2.80K 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |